Saint Kitts and Nevis vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Saint Kitts and Nevis
100.0%
in 2019
Western Pacific (WHO region)
89.0%
in 2024
Saint Kitts and Nevis rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Saint Kitts and Nevis
- Western Pacific (WHO region)
How they compare
Saint Kitts and Nevis currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Saint Kitts and Nevis's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 6 shared years of data; in 2010 it was Western Pacific (WHO region) ahead.
Saint Kitts and Nevis ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Saint Kitts and Nevis has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Saint Kitts and Nevis or Western Pacific (WHO region)?
- Saint Kitts and Nevis, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2019.
- What is the difference in new cases tested for rr-/mdr-tb between Saint Kitts and Nevis and Western Pacific (WHO region)?
- 11.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and Western Pacific (WHO region)?
- 6 years are reported by both, from 2010 to 2019.
- How do Saint Kitts and Nevis and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Saint Kitts and Nevis ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.